What is the market doing?
What the tape says about AVBP
ArriVent BioPharma, Inc. is +58% over the past year while the S&P 500 is +20%: 37 points ahead of the market.
+58%
1-year return · S&P 500 +20%
- vs 200-day average
- +17%
vs 200-day average · a clear uptrend
- RSI (14)
- 57
RSI (14) · neutral
- Below its 52-week high
- 10%
Below its 52-week high
Details›
- Last close2026-09-08
- $30.31
- 1 monthS&P 500 −0.30%
- −2.3%
- 1 yearS&P 500 +20%
- +58%
- vs 50-day average$30.90
- −1.9%
- 52-week high
- $33.83
- 52-week low
- $17.17
- Annualised volatility
- 56%
| Year | Return |
|---|---|
| 2026 (year to date) | +51% |
| 2025 | −24% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 2 | 2 of 2 | +9.5% |
| Feb | 3 | 1 of 3 | −5.1% |
| Mar | 3 | 1 of 3 | −13% |
| Apr | 3 | 2 of 3 | +14% |
| May | 3 | 1 of 3 | +4.9% |
| Jun | 3 | 2 of 3 | +3.3% |
| Jul | 3 | 1 of 3 | −1.2% |
| Aug | 3 | 2 of 3 | +6.7% |
| Sep | 3 | 1 of 3 | −4.9% |
| Oct | 2 | 2 of 2 | +13% |
| Nov | 2 | 2 of 2 | +12% |
| Dec | 2 | 0 of 2 | −12% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.